ABSTRACT
Fusobacterium nucleatum—a gram-negative anaerobe—is commensal to the oral cavity, where it plays an important role in the maturation of the oral biofilm. The bacterium is also an opportunistic pathogen, given its association with systemic infections and cancer progression. Although residing in largely anoxic microenvironments within the oral biofilm, F. nucleatum encounters oxygen (O₂) present in the circulating saliva and reactive oxygen species formed endogenously, by an activated immune system or neighboring oral commensal streptococci. This review explores the bacterium’s adaptive mechanisms that enable survival under oxidative stress. We discuss how F. nucleatum mitigates oxidative damage and aerobic stress through common detoxifying and repair enzymes such as peroxiredoxins, methionine sulfoxide reductases, and rubrerythrin and through the activity of the recently identified multicomponent enzyme, termed butyryl-CoA oxygen oxidoreductase. Turnover by the latter enzyme enables F. nucleatum to exploit molecular oxygen for the conservation of energy. Additionally, we discuss how a two-component signal transduction system, ModRS, a global regulator of oxidative stress, functions in part to reprogram core metabolism to counterbalance the inactivation of a glycyl radical enzyme hypersensitive to O2. Our findings provide new insight into how F. nucleatum resists fluctuating dioxygen environments, shedding light on its persistence in extraoral sites and its potential role in disease progression.
KEYWORDS: Fusobacterium nucleatum, aerobic stress, flavodiiron proteins, glycyl-radical enzymes, methionine sulfoxide reductase, ModRS
INTRODUCTION
Fusobacterium nucleatum—a gram-negative, non-spore-forming anaerobe—is commensal to the oral cavity, where it helps shape the maturation of the oral biofilm through both physical interactions and metabolic cross-feeding (1–3). Recent gene-based imaging of the human oral biofilm shows that prominent bacterial taxa form a highly structured community that creates distinct microenvironments to which individual taxa preferentially localize (4). In short, the mixed species community is radially arranged with obligate or facultative aerobes on the periphery and obligate anaerobes in the core or annulus layer. F. nucleatum inhabits the annulus layer adjacent to commensal streptococci localized at the periphery. Although the circulating saliva contains dissolved O2, aerobic metabolism by peripheral species inevitably depletes O2 concentration below the surface of the biofilm, such that the obligate anaerobes of the annulus and core layers reside in a largely anoxic environment (5). However, the biofilm is dynamic, and organisms residing in these anoxic micro-niches are likely subject to episodic O2 exposure, adversely affecting key enzymes of primary metabolism (6). As with any oral microbe, F. nucleatum is also subject to oxidative stress in the form of reactive oxygen species (e.g., O2●−, H2O2, ●OH), which can form endogenously through adventitious electron transfer to O2 from reduced flavin cofactors, by neighboring oral commensal streptococci or an activated host immune system (7, 8). An adaptive response to O2 and oxidative stress could be an important factor that enables the bacterium to play a prominent role in shaping the oral biofilm.
Tolerance to O2 and reactive oxygen species (ROS) could also contribute to the remarkable ability of F. nucleatum to disseminate to extra-oral sites, which is a major concern to human health as infection of these sites can trigger or exacerbate disease (9). For example, F. nucleatum has been detected in the amniotic fluid and/or fetal tissues of individuals with adverse pregnancy outcomes, including placental infections and pre-term births (10–12). The link between F. nucleatum and pre-term births was further supported in an animal study in which mice intravenously injected with F. nucleatum exhibited an increased incidence of intrauterine infections and adverse pregnancy outcomes (13).
F. nucleatum has been labeled an oncomicrobe due to its association with various cancers. Metagenomic studies of different cohorts show an abundance of the bacterium in adenomas and tumors of the colon, esophagus, pancreas, and breast (14–18). Critically, the abundance of F. nucleatum in colorectal carcinoma, esophageal, and pancreatic cancer correlates with worse patient outcomes and a higher recurrence rate (19–22). Key virulence features of F. nucleatum are its adhesion proteins (FadA, Fap2, and RadD), which bind to surface-exposed receptors on cancer cells, triggering signaling cascades that promote tumor growth, metastasis, and chemoresistance (23–29). The Fap2 adhesion also enables F. nucleatum to bind T cell immunoreceptor with Ig and ITIM domains (TIGIT), an inhibitory receptor of human natural killer cells, which inhibits this class of immune cells from killing tumors (30). The oral microbe is also highly invasive and can enter diverse cell types, including oral, colonic, placental and epithelial cells, T cells, and macrophages (31–34). Cell invasion induces a pro-inflammatory response, further exacerbating the disease. DNA linkage analysis revealed that F. nucleatum present in colonized tumors and amniotic fluid originated from the subgingival plaque, but it is still unclear if the organism travels hematologically, via host cells and/or the gastrointestinal system (35–37). Regardless of the route of transmission, the bacterium likely encounters O2 and ROS during transit, colonization of host tissue, and interaction with the host immune system. Thus, survival in the oral cavity and at systemic sites suggests that the organism has a robust system that defends against transient exposure to O2 and ROS.
Indeed, classical microbiological experiments have shown that F. nucleatum does exhibit a degree of aerotolerance, particularly in a biofilm and upon coaggregation with other bacteria (38–40). In co-culture, F. nucleatum supported the growth of the obligate anaerobe and oral pathogen Porphyromonas gingivalis, conditions in which P. gingivalis, in a monoculture, did not survive (41). In fact, F. nucleatum grew slightly but significantly better in co-culture with P. gingivalis under moderate oxygen levels (10%) compared with strict anaerobic conditions, indicating that it may benefit from low levels of the diatomic gas, at least in mixed cultures. The ability of F. nucleatum to cope with episodic oxygenation was further examined in a study that involved growing the bacteria in continuous culture under increasing partial pressures of O2 (42). Strikingly, cell viability was unaltered with temporary O2 exposure. The study also noted a shift in the fermentation end-products produced by the culture, with a depletion in butyrate coinciding with an increase in O2 tension. Conversely, the concentration of acetate increased with incremental increases in molecular oxygen. These results suggest that F. nucleatum shifts its metabolism to mitigate O2 exposure.
Herein, we examine environmental sources of ROS in relation to F. nucleatum’s natural environmental niche and its propensity to infect other tissues. Potential strategies by which F. nucleatum not only shields itself against episodic exposure to O2 but uses the diatomic gas to conserve energy are also reviewed. Similar to other anaerobes, F. nucleatum encodes a repertoire of enzymes that mitigate against oxidative stress by either directly detoxifying O2 or H2O2, repairing damaged cellular machinery, or functioning as a substitute for the damaged enzyme; each of these systems will be highlighted herein. Finally, we discuss how a two-component signal transduction system, ModRS, reprograms metabolic pathways to circumvent the O2 inactivation of a central metabolic enzyme.
ENVIRONMENTAL SOURCES OF ROS
In the annulus layer of the oral biofilm, F. nucleatum neighbors oral commensal streptococci (e.g., Streptococcus sanguinis, Streptococcus gordonii, Streptococcus oralis, Streptococcus mitis) (40). These lactic acid bacteria can grow under aerobic or anaerobic conditions and, thus, are well adapted to living in a dynamic oral biofilm with fluctuating O2 levels. In the absence of molecular oxygen, oral streptococci metabolize glucose via the Embden-Meyerhof-Parnas (EMP) pathway (Fig. 1). Lactic acid bacteria lack a full respiratory chain and a complete TCA cycle; consequently, pyruvate is reduced to lactate by lactate dehydrogenase, a process that regenerates NAD+ consumed in the EMP pathway. However, under aerobiosis, pyruvate oxidase, a flavoenzyme, converts pyruvate, orthophosphate, and O2 to acetyl-phosphate, CO2, and H2O2 (43, 44). Acetyl-phosphate is then used by acetate kinase to form ATP. Likewise, the presence of O2 enables lactate to be converted back to pyruvate by the action of lactate oxidase, another H2O2-generating flavoenzyme. Thus, oral commensal streptococci produce H2O2 via two flavin-dependent systems that operate during aerobiosis.
Fig 1.
Environmental sources of ROS. F. nucleatum populates the oral biofilm alongside streptococci. As lactic acid bacteria, oral streptococci convert glucose to pyruvate through the EMP pathway. In the absence of O2, pyruvate is converted to lactate by lactate dehydrogenase, a reaction that recycles NADH to NAD+. In the presence of O2 and HPO32-, pyruvate is oxidized to acetyl-phosphate by pyruvate oxidase, producing CO2 and H2O2 as byproducts. H2O2 is also a byproduct of the O2-dependent oxidation of lactate to pyruvate by lactate oxidase. H2O2 reacts with Fe2+ to form Fe3+, -OH, and the highly potent oxidant, •OH. Adventitious electron transfer from reduced endogenous flavoproteins to O2 is also a potential source of H2O2. Finally, activated immune cells can produce reactive oxidants, O2-•, and HOCl through the action of NADPH oxidase and myeloperoxidase.
Exposure to H2O2 can damage the cell as it rapidly reacts with a labile ferrous iron, leading to the formation of a highly reactive hydroxyl radical (·OH; Fig. 1) (45). Although the hydroxyl radical can oxidize proteins and lipids, its reaction with DNA is the most damaging to the organism, since even a single lesion can be lethal or mutagenic. Production of H2O2 by oral commensal streptococci is thought to be beneficial to oral health as mixed culture studies have shown that several H2O2-producing species of oral commensal are antagonistic to the growth of Streptococcus mutans, a pathogenic species associated with dental caries (46–51). Until recently, it was not evident that the antagonistic effect of H2O2 extended to the oral cavity, but Kim et al. demonstrated that a high-producing H2O2 strain of S. oralis J22 was able to inhibit the clustering, accumulation, and spatial organization of S. mutans on an ex vivo human tooth surface. Moreover, coinfection of S. mutans with S. oralis resulted in reduced caries development in an in vivo rodent caries model (52). Streptococci do not possess the H2O2-degrading enzyme catalase but do encode for homologs of AhpCF, a cysteine-based peroxidase and reductase that has been shown in other bacteria to mitigate against H2O2 toxicity (53, 54). Streptococci also mitigate against the formation of ·OH by reducing their reliance on iron-containing proteins and using manganese rather than iron to metalate key enzymes (55).
Earlier work on strains of E. coli deficient in ROS scavenging enzymes (e.g., catalase and superoxide dismutase) revealed that H2O2 and O2•- can also form endogenously under aerobic growth conditions as a result of adventitious electron transfer to dioxygen from flavin-dependent enzymes (45, 56, 57). For example, Hrb from Moorella thermoacetica, an NADPH-dependent dehydrogenase that contains an FMN cofactor and [Fe(SCys)4] rubredoxin domain can—at least in vitro—donate electrons to O2 instead of its natural redox partner, a flavodiiron protein (58). Likewise, acyl-CoA dehydrogenases, which possess a solvent-exposed FAD cofactor, are also noted for their ability to adventitiously donate electrons to O2 instead of its physiological redox partner, an electron transfer flavoprotein (59).
Cytotoxic ROS are also produced enzymatically by activated neutrophils and macrophages as a means to control the growth of extracellular or intracellular pathogens. When neutrophils engulf bacteria, they enclose them in small vesicles (phagosomes) into which superoxide is released by an activated NADPH-dependent oxidase on the internalized neutrophil membrane (Fig. 1) (60). The superoxide can rapidly dismutate to hydrogen peroxide, which myeloperoxidase uses to peroxidate chloride, forming hypochlorous acid (HOCl) (61). HOCl is membrane-permeable. It is also a strong two-electron oxidant that is very effective at both oxidation and chlorination of certain amino acids, which can lead to protein misfolding and aggregation and, ultimately, cell death (62–64).
F. nucleatum can be delineated into five subspecies nucleatum, animalis, vincentii, fusiform, and polymorphum, which are all members of the oral microbiota (65, 66). Genetic analysis of these subspecies reveals that they lack key enzymes commonly known to detoxify ROS, including superoxide dismutase, superoxide reductase, and catalase. However, they do encode two discrete enzyme systems that have been shown in other bacteria to use thiol-based chemistry to mitigate oxidative damage caused by peroxides. The first is an alkyl hydroperoxide reductase (AhpC), which belongs to a widely distributed class of peroxiredoxins that reduce hydrogen peroxide, peroxynitrite, and organic hydroperoxides (ROOH) (67). The second is methionine sulfoxide reductases (MsrA and MsrB) that reduce methionine sulfoxides that form from exposure to reactive oxidizing species (68). In addition, F. nucleatum encodes for rubrerythin and flavodiiron proteins demonstrated in other organisms to utilize a diiron motif to reduce H2O2 or O2, respectively. Herein, we review the enzymology of these repair enzymes as well as other proteins involved in the F. nucleatum oxidative stress response. Conservation of the genes across all subspecies of F. nucleatum points to their importance in adaptation to the oral biofilm and dissemination to extra-oral sites. Gene IDs are provided for F. nucleatum subsp. nucleatum ATCC 28856, the first strain to be sequenced (69). However, we have cross-listed all gene IDs with those of F. nucleatum subsp. nucleatum ATCC 23726, as the genetic trackability of this particular strain has uncovered important information on the organism’s oxidative stress response (Table S1).
PEROXIREDOXIN AND PEROXIREDOXIN REDUCTASE
F. nucleatum contains a peroxiredoxin homolog (FN1983) that shares 60% sequence identity with well-characterized peroxiredoxin of Salmonella enterica serovar Typhimurium (AhpCSE), which has been shown to confer resistance to alkyl hydroperoxides and H2O2 by reducing these compounds to alcohols and water, respectively (70–72). Based on biochemical and structural data of AhpCSE, the peroxide reduction initiates with a redox-active cysteine, called the peroxidate cysteine (Cys-Sp-H), attacking the peroxide substrate (Fig. 2) (67, 73). Cleavage of the O-O bond is assisted by general acid catalysis owing to the poor leaving group properties of the RO- group. This first reaction step leads to the release of alcohol (or water if the substrate is H2O2) and the formation of a sulfenic acid intermediate (Cys-Sp-OH). A resolving cysteine (Cys–SR-H) then attacks the sulfenic acid intermediate, resulting in the release of water and the formation of a disulfide bond.
Fig 2.

Structure and mechanism of peroxiredoxins and peroxiredoxin reductase. (A) The catalytic cycle of peroxiredoxin initiates with proton abstraction from the peroxidatic cysteine (-SP-H) resulting in a thiolate anion that attacks the alkyl peroxide or hydrogen peroxide substrate. Proton-assisted cleavage of the O-O bond results in the release of alcohol or water and the formation of a sulfenic acid (R-S-OH). A resolving cysteine (Cys–SR-H) then attacks the sulfenic acid intermediate, resulting in the release of water and the formation of a disulfide bond. The N-terminal domain AhpF, an NADH-dependent flavin disulfide oxidoreductase, reduces the disulfide of AhpC through a thiol exchange mechanism (67). In F. nucleatum, ahpC and ahpF may have independent transcriptional start sites, as RNA sequencing data suggests (74). (B) Molecular structure of dimeric AhpFSE (PDB ID: 1HYU) with one subunit colored green and the second subunit colored gray (75). The N-terminal domain comprises two contiguous thioredoxin folds, with a single pair of redox-active cysteines (spheres) circled. In AhpF from F. nucleatum, this domain is located at the C-terminus. The FAD cofactor is shown as a sphere. (C) The decameric assembly of AhpCSE is shown as a pink cartoon with one individual subunit in grey (PDB ID: 1YEX) (76).
In S. enterica, a gene encoding an NADH-dependent flavin disulfide oxidoreductase (AhpFSE) is dicistronic with ahpCSE (77). AhpFSE is a modular enzyme with C-terminal-most 314 amino acids homologous to FAD-containing thioredoxin reductase of Escherichia coli and the N-terminal-most 200 amino acids consisting of two fused thioredoxin folds (Fig. 2) (75, 78, 79). AhpFSE catalyzes the oxidation of NADH and transfers reducing equivalents via the FAD cofactor and two conserved cysteines of the thioredoxin reductase domain (Cys345 and Cys348; AhpFSE numbering) to a pair of cysteines (Cys129 and Cys132) in one of the thioredoxin folds of the N-terminus. This reduced thiol pair then reduces the disulfide bond following the turnover of AhpCSE (73, 80). The gene product encoded upstream of ahpC (FN1984) in F. nucleatum is also comprised of a thioredoxin reductase domain and a second domain consisting of two fused thioredoxin folds. However, unlike AhpFSE, the former domain is at the C-terminus, whereas the latter is at the N-terminus. The difference in modular organization suggests that AhpF formed twice during evolution. RNA-sequence analysis performed by Ponath et al. further suggests that ahpC and ahpF each have their own promoter; thus, they are independently transcribed (74).
Peroxiredoxin was long thought to be ∼1,000 times less catalytic efficient toward H2O2 reduction than the historically better-known catalase. However, it was revealed through the development of a sensitive spectral assay in which disulfide reduction was not rate-limiting, that AhpC from S. typhimurium had a kcat/KM for H2O2 of 107-108 M−1 s−1, surpassing that of catalase (106 M−1 s−1) and approaching the limiting rate of diffusion (72, 76). Further underscoring its biological importance in scavenging H2O2 was the observation that AhpC—not catalase—was responsible for the reduction of H2O2 in E. coli (81). Thus, although F. nucleatum does not encode a catalase, it possesses homologs of AhpC and AhpF that may be sufficient to mitigate the damaging effects of alkyl hydroperoxides and H2O2.
METHIONINE SULFOXIDE REDUCTASE
The thioether side chain of methionine is particularly susceptible to oxidation by ROS and reactive chlorine species, leading to protein dysfunction (82). Of potential oxidants, •OH and HOCl are the most potent oxidizers of methionine, exhibiting second-order rate constants of 3.8 × 107 M−1 s−1 and 8.9 × 109 M−1 s−1 (pH 7), respectively (83, 84). By comparison, the corresponding rate constant for H2O2 oxidation of methionine is 6 × 10−3 M−1 s−1 (85)! Oxidation of the thioether side chain generates methionine sulfoxide (-SO-) in either the (R-) or (S-) diastereomeric form. Methionine sulfoxide reductases (Msr), which are found in most living organisms, repair the damaged side chain by catalyzing the reduction of methionine sulfoxide to methionine, a reaction that consumes two protons and generates a water molecule (86). Many organisms encode MrsA and MsrB, which exhibit stereospecificity toward the (R-) or (S-) diastereomers of methionine sulfoxide, respectively (87–89). In F. nucleatum, as in some other bacteria, the two reductases are translated as a fusion protein labeled MsrAB. Although MsrA and MsrB are structurally distinct, they both use a thiol-dependent mechanism to reduce the sulfoxide (90–93). The proposed reaction initiates with nucleophilic attack of the sulfoxide by a deprotonated active site cysteine, which generates a tetrahedral transition state that undergoes rearrangement, resulting in the release of methionine and formation of a sulfenic acid intermediate (Fig. 3) (94). The attack of the sulfenic acid intermediate by a second deprotonated cysteine results in the formation of a disulfide bond and the release of water. Regeneration of an active MsrAB occurs through a disulfide exchange mechanism involving a thioredoxin-like protein (95).
Fig 3.

Methionine sulfoxide reductase. F. nucleatum contains two separate gene clusters encoding for a fused protein containing MsrA and MsrB. (A) At the first genetic locus (left), msrAB1 encodes MsrAB1 with an N-terminal thioredoxin domain, similar to PilB from N. meningitidis (96, 97). Contiguous with msrAB1 is ccdA, encoding CcdA, a transmembrane protein that likely shuttles electrons from intracellular Trx to MsrAB1 for the reduction of methionine sulfoxides (97). (B) At the second locus (right), msrAB2 is clustered with ccdA, eTrx modR, and modS, which encode CcdA, eTrx (extracellular thioredoxin), and ModRS, a two-component signal transduction system that acts as a global oxidative stress response regulator (98). (C) The proposed Msr reaction begins with a nucleophilic attack on the sulfoxide by a deprotonated active site cysteine, forming a tetrahedral transition state that undergoes rearrangement. This leads to the release of methionine and the formation of a sulfenic acid intermediate (94). A second deprotonated cysteine then attacks the sulfenic acid, resulting in the formation of a disulfide bond and the release of water. The active MsrAB enzyme is regenerated through a disulfide exchange mechanism involving a thioredoxin-like protein (95).
F. nucleatum contains two copies of msrAB, msrAB1 (FN0188), and msrAB2 (FN0803), encoded at distinct gene clusters (Fig. 3). MsrAB1 (473 amino acids) contains an additional N-terminal thioredoxin-like domain fused to the tandem Msr A and B components. This domain organization is similar to that of PilB from Neisseria gonorrhoeae (50% sequence identity) (92). Biochemical studies of PilB confirmed that the N-terminal thioredoxin domain reduces the disulfide bridge formed during the turnover of MsrAB (96). Notably, homologs of PilB have a narrow phylogenetic distribution, being found to date in select genera within the families of Neisseriaceae (Eikenella sp., Neisseria sp., and Kingella sp.), Moraxellaceae (e.g., Moraxella sp. and Psychrobacter sp.), and Fusobacteriaceae.
In F. nucleatum, msrAB1 is dicistronic with a gene encoding a cytochrome c biogenesis A (CcdA)-like protein. NMR experiments of an archaeal CcdA homolog revealed that this transmembrane protein employs a single pair of cysteine residues and a conformational switch mechanism that enables the transfer of reducing equivalents derived from cytoplasmic thiols (e.g., reduced thioredoxin) to extracellular disulfides (e.g., oxidized periplasmic thioredoxins) (97, 99, 100). F. nucleatum does encode thioredoxin (trx; FN0093) and an NADPH-dependent thioredoxin reductase (trxR; FN1163) that may supply reducing equivalents to CcdA. Analysis of MsrAB1 by SignalP 6.0 indicates a periplasmic targeting sequence, suggesting that MsrAB1, along with the accessory proteins, protects periplasmic and outer membrane proteins from exogenous oxidative stress (101).
MsrAB2 (FN0188; 298 amino acids) is part of a five-gene cluster that also includes genes for a two-component signal transduction system (ModRS), a thioredoxin-like protein (eTrx), and a cytochrome c (CcdA)-like protein. Notably, these five genes were upregulated upon exposure of F. nucleatum to 1 mM H2O2. Although this concentration of H2O2 is not physiologically relevant, it may have resulted in sufficient protein damage to trigger the upregulation of msrAB2. The importance of MsrAB2 in the oxidative stress response was established through a ΔmsrAB2 strain, which exhibited higher sensitivity to H2O2 and a weakened ability to invade colorectal epithelial cells and survive in macrophages compared to the parental strain (98). These resulting phenotypes mirror those of ΔmsrAB strains of other bacterial pathogens, which also exhibited reduced fitness and virulence in different infection models (102–106). Unlike MsrAB1, analysis of the MsrAB2 (FN0188) sequence using SignalP 6.0 [14] revealed that the protein does not carry a known signal for translocation to the periplasm. Thus, MsrAB2 is likely cytosolic and functions to reduce methionine sulfoxides on intracellular proteins. However, the adjacent thioredoxin-like gene does encode for an N-terminal signal sequence, and the presence of ccdA in the operon suggests that the combined function of CcdA and eTrx is to translocate electrons from reduced thiol proteins in the cytosol to a periplasmic eTrx for reduction of oxidatively damaged proteins.
RUBRERYTHRINS
Rubrerythrin is a non-heme iron protein first isolated from the anaerobic sulfate-reducing bacterium Desulfovibrio vulgaris (107). Extensive genetic and microbiological studies of rubreythrins from D. vulgaris and other anaerobes show that this enzyme mitigates against oxidative stress primarily by reducing hydrogen peroxide to two equivalents of H2O (108–111). In vitro, rubrerythrin from Clostridium difficile and Clostridium acetobutylicum was also shown to function as an O2 reductase, but the measured activity was 2 to 7-fold lower compared with peroxidase activity (112, 113). Rubrerythrins comprise an N-terminal four ⍺-helical bundle of the ferritin superfamily and a C-terminal rubredoxin domain (Fig. 4) (114, 115). The former domain provides residues for the assembly of a diiron motif. In contrast, the latter domain contains a [Fe(SCys)4] site, whereby a single iron atom is coordinated via sulfur atoms of four cysteine residues. The reduced diiron site reacts directly with hydrogen peroxide, whereas the [Fe(SCys)4] cluster transfers electrons from an exogenous donor to a μ−1,2-H2O2 intermediate that forms at the diiron site (116). In vitro studies have established that rubreythrin from C. acetobutylicum and C. difficile can receive electrons from an NADH-dependent rubredoxin oxidoreductase and a rubredoxin (112, 113). F. nucleatum encodes for rubreythrin (FN0455), but the role of this protein in the oxidative stress response has not been determined.
Fig 4.

Structure of rubrerythrin. Head-to-tail dimeric structure of rubrerythrin from D. vulgaris (PDB ID 1LKM) (115). The C-terminal rubredoxin domain with the [Fe(SCys)4] domain of one monomer is colored cyan while the N-terminal four ⍺-helical bundle of the ferritin family is colored light green. The second monomer is colored gray. The iron atoms are depicted as orange spheres. The [Fe(SCys)4]2+ redox cluster receives electrons (one at a time) from an external reductant, which it subsequently transfers to the diiron motif present in the ⍺-helical bundle rubredoxin domain. Two sequential one-electron transfers facilitate the peroxidase activity of rubrerythrin.
BUTYRYL-COA OXYGEN OXIDOREDUCTASE
Flavodiiron proteins (FDPs) are commonly found in obligate anaerobes, where they mitigate oxidative and/or nitrosative stress by reducing O2 to H2O and/or NO to N2O (117–119). The simplest FDPs (referred to as class A FDPs) comprise two domains: an N-terminal metallo-β-lactamase module harboring a catalytic diiron center and a C-terminal flavodoxin module that binds FMN (120). This core unit assembles into a “head” to “tail” homodimer, enabling efficient electron transfer from the FMN of one monomer to the diiron center of the second monomer (121, 122). Bioinformatic analysis has revealed that FDPs can be fused to additional domains (e.g., rubredoxin domain, a domain with a [4Fe-4S] cluster, an NAD(P)H:flavin oxidoreductase, and NADH: rubredoxin oxidoreductase), which all ostensibly serve to shuttle electrons to the FDP (123, 124). The variations in domain assemblies have resulted in nine distinct classes of FDP (class A to I). For most FDPs studied to date, a reduced pyridine nucleotide serves as the primary source of electrons for reducing O2 and/or NO at the diiron catalytic site (120, 125–127).
F. nucleatum encodes for two FDPs: FN1423 and FN0512. The latter is monocistronic, whereas the former is of particular interest, as it is bicistronic with a gene encoding a multidomain enzyme comprising an N-terminal butyryl-CoA dehydrogenase (Bcd) domain, the C-terminus of the ⍺-subunit of electron transfer flavoprotein (EtfA), and a rubredoxin (128). We have termed this fusion protein butyryl-CoA reductase (BCR). Our biochemical analysis of BCR and the adjacently encoded FDP revealed that the two proteins form an ⍺4β4 complex and together couple the oxidation of butyryl-CoA to crotonyl-CoA with the reduction of O2 to H2O. Unlike other FDPs, the BCR-FDP complex did not exhibit NO reductase activity; thus, it functions solely as a butyryl-CoA oxygen oxidoreductase (BOOR), which the enzyme now labeled (128). Using butyryl-CoA, a relatively weak thermodynamic reductant (E°’ = −10 mV), instead of the more moderate reductant, NAD(P)H (E°’ = −320 mV) to reduce O2 to H2O (E°’ = +820 mV) enables F. nucleatum to conserve free energy in the detoxification of O2 (129). Notably, differential gene expression analysis revealed that the BCR gene was upregulated during planktonic growth compared to biofilm growth, environmental conditions where the bacteria may be more likely exposed to O2 from the surrounding environment (130).
BOOR conversion of butyryl-CoA to crotonyl-CoA is another mechanism by which F. nucleatum conserves energy. F. nucleatum preferentially utilizes lysine, histidine, and glutamate as a source of carbon and nitrogen, and the product of these three amino acid fermentation pathways is crotonyl-CoA (Fig. 5) (131–134). Crotonyl-CoA serves as the terminal electron acceptor for the bifurcating butyryl-CoA dehydrogenase-electron transfer flavoprotein (Bcd-ETF; FN0783-FN0785) complex. Bcd-Etf, first characterized from the strict anaerobe, Clostridium kluyveri, couples NADH-dependent reduction of crotonyl-CoA (an exergonic reaction) to butyryl-CoA with the NADH-dependent reduction of flavodoxin (an endergonic reaction) (135, 136). The reduced flavodoxin then transfers electrons to the Rnf (Rhodobacter capsulatus nitrogen fixation) complex, which facilitates the reduction of NAD+ and the establishment of the Na+-electrochemical gradient (137, 138). The ion motif force can then be used to drive ATP synthesis or import amino acids. Genetic disruption of a component of the Rnf complex (rnfC) in F. nucleatum underscored the importance of this respiratory enzyme (139). The deletion strain exhibited reduced amino acid fermentation and ATP production, altered cell morphology and growth, and reduced biofilm formation and virulence. The Bcd-Etf and Rnf complexes are key energy-conserving and converting systems for the fermentative metabolism of F. nucleatum; BOOR integrates into this respiratory system in the presence of O2. The ability of F. nucleatum via BOOR to exploit O2 for energy conservation may account for the modest increase in bacterial growth observed in 10% O2 compared with strict anaerobic conditions, at least in mixed cultures with P. gingivalis (40).
Fig 5.

Energy conservation by butyryl-CoA oxygen-oxidoreductase (BOOR). The butyryl-CoA reductase (BCR) subunit of BOOR catalyzes the oxidation of butyryl-CoA to crotonyl-CoA, transferring reducing equivalents to the flavodiiron protein (FDP) subunit, enabling the reduction of O2 to H2O at the diiron motif (128). Crotonyl-CoA produced by BOOR turnover can be used by the bifurcating Bcd-ETF complex to generate 2-electron reduced flavodoxin (Fldhq) at the expense of NADH oxidation. Fldhq can then transfer electrons to the Rnf complex, regenerating the one-electron reduced semiquinone form of the flavodoxin (Fldsq) (139, 140). This electron-transfer step is used to reduce NAD+ to NADH and create an ion motive force across the cytoplasmic membrane, which then can be used for ATP synthesis by an ATP synthetase. Acetoacetate:butyryl-CoA transferase (FN0272 and FN0273, labeled 1) can transfer the CoA to acetoacetate (formed during lysine fermentation) to form butyrate and acetoacetyl-CoA. This product can also be formed by acetyl-CoA acetyltransferase (FN0495, labeled 2) with two equivalents of acetyl-CoA. Acetoacetyl-CoA then undergoes reduction by 3-hydroxybutyryl-CoA dehydrogenase (FN1020) to 3-hydroxybutyryl-CoA, which condenses to crotonyl-CoA by hydroxybutyryl-CoA dehydratase (FN1019).
BOOR turnover may also account for reduced concentrations of butyrate in the media that resulted from temporary exposure of the bacterial culture to O2 (42). Butyrate is released from butyryl-CoA through the action of acetoacetate:butyryl-CoA transferase (FN0272, FN0273), which relocates the CoA moiety to acetoacetate (product of lysine fermentation). The resulting acetoacetyl-CoA undergoes reduction to 3-hydroxybutyryl-CoA by 3-hydroxybutyryl-CoA dehydrogenase (FN1020), and hydroxybutyryl-CoA dehydratase (FN1019) condenses 3-hydroxybutyryl-CoA to crotonyl-CoA. BOOR turnover redirects butyryl-CoA to crotonyl-CoA, resulting in less butyrate formation. Thus, O2 appears to modulate the amount of butyrate exported by the bacterium, which could impact oral health, given the multifaceted role of the short-chain fatty acid in modulating the host immune system and the growth of other oral microbes (141).
From another perspective, the combined action of BOOR, Rnf, and Bcd-ETF may contribute to the aerotolerance of F. nucleatum and its ability to colonize a wide array of extra-oral tissues. Electron bifurcation by Bcd-Etf regenerates butyryl-CoA (fueling further BOOR turnover) while producing low-potential reductants (e.g., reduced flavodoxin) at the expense of NADH. The Rnf complex integrates into the oxidative stress response by regenerating NADH and oxidized flavodoxin for further butyryl-CoA production by Bcd-Etf. It is worth noting that this system is not unique to F. nucleatum, as many obligate anaerobes of the Firmicute phyla, including dominant butyrogenic bacteria that are beneficial to gut health, encode for BOOR, Rnf, and Bcd-Etf (128, 142). The BOOR/Rnf/Bcd-Etf also mimics, in part, the pyruvate oxidase and lactate oxidase system of lactic acid bacteria, which also exploit O2 to enhance ATP yield (44).
METABOLIC REPROGRAMMING BY MODRS
As stated above, the two-component signal transduction system (ModRS) was shown to upregulate a number of gene clusters involved in methionine sulfoxide reduction (msrAB2) as well as gene loci involved in the catabolism of histidine, methionine, and ethanolamine (98). Genes downregulated include those involved in de novo purine biosynthesis and the phosphotransferase system for fructose utilization. We suggest that this suite of genes not only compensates for the damaging effects of ROS but also counteracts the detrimental effects of O2. Even transient exposure to O2 leads to the endogenous formation of ROS, as the oral microbe encodes a flavin-dependent dehydrogenase and reduced flavodoxins that can in vitro spuriously donate electrons to O2 when populating the reduced hydroquinone state (unpublished data). Given that the damaging effects of ROS are a consequence of O2 exposure, ModRS may function to circumvent the damaging effects of both.
The upregulation of histidine catabolism helps support one-carbon folate metabolism following the O2-inactivation of a glycyl-radical enzyme, pyruvate formate lyase. Like other bacteria, F. nucleatum degrades histidine to glutamate and ammonia via the histidine utilization (hut) system (Fig. 6) (134, 143). The first three steps of the pathway are universal and initiated with histidine ammonia lyase (encoded by hutH, FN1406), catalyzing the non-oxidative deamination of L-histidine to trans-urocanic acid and ammonia. In the second step, urocanase (imidazolone-propionate hydrolase; hutU) employs a tightly bound NAD+ cofactor for the conversion of trans-urocanic acid to hydroxy-imidazolyl-propionate, which tautomerizes spontaneously to form 4-imidazolone-propionate. Imidazolonepropionase (encoded by hutI; FN1404) catalyzes the third step: hydrolysis of the carbon-nitrogen bond in 4-imidazolone-5-propionate to yield N-formimino-L-glutamate.
Fig 6.
Circumvention O2 inactivation of pyruvate formate lyase. Molecular oxygen irreversibly inactivates pyruvate formate lyase, which converts CoA and pyruvate to formate and acetyl-CoA. Formate can be used by formate tetrahydrofolate ligase to form N10-formyl-tetrahydrofolate (N10-formyl-THF), which feeds into the one-carbon folate pool required for de novo purine, thymidylate, and formyl-met tRNA biosynthesis. FolD is a bifunctional tetrahydrofolate dehydrogenase and cyclohydrolase that interconverts N10-formyl-THF, to N5, N10-methenyl-THF to N5, N10-methenylene-THF. Following the transfer of the methyl group to dUMP by thymidylate synthase, the resulting dihydrofolate (DHF) is converted to THF by dihydrofolate reductase. ModRS upregulates histidine fermentation, which can contribute to the one-carbon folate pool as shown. Likewise, ModRS enhances the expression of enzymes and proteins involved in the conversion of ethanolamine to acetyl-CoA and L-cysteine to acetyl-CoA (98).
Further degradation of N-formimino-L-glutamate can occur via one of three pathways; it can be hydrolyzed to glutamate and formamide by formimino-L-glutamate hydrolase (hutG) or deaminated by iminohydrolase (hutF) to form ammonia and formylglutamate (hutF), which is then converted to glutamate and formate by formylglutamate deformylase. In a third pathway, which occurs in mammals and some bacteria, including F. nucleatum, degradation of N-formimino-L-glutamate is coupled to one-carbon folate metabolism (144). Glutamate formiminotransferase (FN1407) initially transfers the formino group from N-formimino-L-glutamate to the N5 of tetrahydrofolate (THF) to form N5-formimino-THF and glutamate. Formiminotetrahydrofolate cyclodeaminase (FN1405) then catalyzes the deamination of N5-forming-THF to form ammonia and N5, N10-methyl-THF. The latter product can be directly converted to N10-formyl-THF or N5, N10-methylene-THF by the bifunctional enzyme (FN1488) methylenetetrahydrofolate dehydrogenase /methenyltetrahydrofolate cyclohydrolase. In F. nucleatum, N5, N10-methylene-THF is an essential cofactor for thymidylate biosynthesis. At the same time, N10-formyl-THF is used in two enzymatic steps for the de novo biosynthesis of purines and formylation of the initiator tRNA. All of the above-mentioned genes for L-histidine catabolism are clustered along with genes that encode an aminoacyl-histidine dipeptidase, histidine permease, and a membrane-spanning protein with an unknown function.
Notably, F. nucleatum can also form N10-formyl-THF by formate tetrahydrofolate ligase (FN2082), which uses ATP to add formate to THF. This latter reaction may be impeded in the presence of O2, as formate is generated by pyruvate formate lyase, a member of the glycyl radical enzyme family, which is known for its hypersensitivity to O2 (145). PFL–a central player in anaerobic primary metabolism reversibly converts pyruvate and coenzyme A to formate and acetyl-CoA (Fig. 7). PFL employs a radical-based mechanism for this reaction to circumvent the bonding electrons’ natural tendency to remain with the C2 during the cleavage of the C1-C2 atoms of pyruvate. The resting form of PFL contains a glycyl radical that is formed through the action of a glycyl-radical enzyme activating enzyme (GRE-AE), a member of the S-adenosyl-methionine-dependent superfamily of enzymes (145–147). GRE-AE utilizes a [4Fe-4S]1+ cluster, which functions to reductively cleave S-adenosyl-L-methionine to form a 5'-deoxyadenosyl radical that abstracts hydrogen from an active site glycine to generate a glycyl radical (148–151). To initiate catalysis, the glycyl radical is proposed to abstract hydrogen from an active site cysteine to form a transient thiyl radical, which then abstracts hydrogen from pyruvate, enabling radical-based cleavage of the C1-C2 bond (152, 153). Following product formation, the glycyl radical is regenerated for the next round of catalysis (145). In the absence of O2, the glycyl radical is stable due to a captodative effect that arises from the combination of electron donation and withdrawal from the neighboring amine and carbonyl groups, respectively (154). In fact, under strict anaerobic conditions, this organic radical can persist for several days in vitro and catalyze numerous turnovers following the initial activation step by the GRE-AE (155). However, the glycyl radical can rapidly convert to peroxide radical in the presence of O2, which leads to cleavage of the polypeptide backbone at the site of the glycine, resulting in irreversible enzyme inactivation (156, 157). In order to cope with the physical loss of a part of the protein, some facultative anaerobes express small proteins called autonomous glycyl radical cofactors that have high sequence similarity to the cleaved region of the glycyl radical enzyme (158). These autonomous glycyl radical cofactors replace the cleaved portion of the enzyme, restoring enzymatic activity (159). However, F. nucleatum does not contain an autonomous glycyl radical cofactor homolog. Instead, it partially copes with irreversible PFL damage by upregulating histidine catabolism to maintain one-carbon folate metabolism. ModRS-mediated down-regulation of de novo purine biosynthesis, which utilizes N10-formyl THF in two steps, may also be a means to spare one-carbon folate metabolism for thymine and protein synthesis.
Fig 7.
Activation and O2 inactivation of pyruvate formate lyase (PFL). PFL is activated by a glycyl radical enzyme activating enzyme (GRE-AE) which uses S-adenosyl-L-methionine (SAM), an electron derived from a reduced flavodoxin, and an embedded [4Fe-4S] redox center to form a highly reactive 5ʹ-deoxyadenosyl radical, which then abstracts hydrogen from an active site glycine to form a glycyl radical on PFL, forming the products, methionine and 5ʹ-deoxyadenosine (5ʹ-dA) (145, 146). The glycyl radical then abstracts hydrogen from an active site cysteine, which enables conversion of pyruvate and CoA to acetyl-CoA and formate. Molecular oxygen reacts with the glycyl radical to form a peroxyl radical, which leads to the cleavage of the polypeptide backbone at the glycyl radical, rendering the protein inactive (156).
The upregulation of genes involved in the transport and catabolism of ethanolamine and methionine would ostensibly bolster the intracellular concentration of the central metabolite acetyl-CoA impacted by a loss of PFL activity. Ethanolamine is a component of the membrane lipid, phosphatidylethanolamine present in eukaryotes and prokaryotes, and the ability to catabolize ethanolamine is facilitated through the ethanolamine utilization (eut) gene cluster. Ethanolamine ammonia lyase—encoded by eutB and eutC—catalyzes the first step of the reaction, the radical-based deamination of ethanolamine to form acetaldehyde and ammonia (160). Acetaldehyde dehydrogenase, encoded by eutE, subsequently converts acetaldehyde and coenzyme A to acetyl CoA.
ModRS also upregulates the gene for methionine ɣ-lyase (megl FN1419) and the nearby gene (FN1421) encoding for a pyruvate flavodoxin oxidoreductase. Although methionine γ-lyase catalyzes the ⍺ɣ-elimination of methionine to form methyl mercaptan, NH3, and 2-isobutyrate, it also can catalyze the ⍺β-elimination of L-cysteine to form H2S, pyruvate, and ammonia (161). In fact, of the four pyridoxal 5'-phosphate-dependent enzymes known to catalyze the desulfurization of L-cysteine, methionine γ-lyase exhibited the highest intracellular activity (162). The pyruvate formed from methionine γ-lyase can serve as a substrate for pyruvate flavodoxin oxidoreductase, which catalyzes the oxidative decarboxylation of pyruvate, transferring electrons to flavodoxin and the acetyl moiety to CoA to form acetyl-CoA. Thus, the combined action of methionine γ-lyase and pyruvate flavodoxin oxidoreductase can supplement the acetyl-CoA pool.
RIBONUCLEOTIDE REDUCTASES
Ribonucleotide reductases (RNR) are essential for providing a balanced pool of deoxynucleotides required for DNA synthesis and repair (163, 164). There are three structurally distinct classes of RNR (I, II, and III), differentiated in part by their use of different cofactors to generate a thiyl radical required to reduce the ribose ring (Fig. 8) (152, 165). Class I RNR generates the thiyl radical by incorporating O2 into a binuclear metal cluster (Fe or Mn). This triggers the formation of a stable tyrosyl radical, which, through a long-range proton-coupled electron transfer, forms thiyl radical (166). Critically, O2 is not required for every equivalent of dNTP product, as the tyrosyl radical is regenerated after each catalytic cycle (167). In contrast, radical formation in Class II and III enzymes is independent of O2. Class II uses adenosylcobalamin (coenzyme B12) to generate a 5'-deoxyadenosyl radical, which then abstracts hydrogen from the active site cysteine to form a thiyl radical. Finally, Class III RNR (NrdD) first forms a glycyl-radical—generated by a GRE-AE (NrdG) using radical S-adenosylmethionine (SAM) [4Fe4S]1+ chemistry—for radical propagation to the active site cysteine. Class II RNR tolerates O2, but NrdD, being a member of the glycyl-radical enzyme family, irreversibly inactivates in the presence of O2. Consequently, NrdD and its associated GRE-AE (NrdG) are found in anaerobic bacteria, including F. nucleatum (FN0311 and FN0312).
Fig 8.
Class I and class III ribonucleotide reductases. (A) The class III ribonucleotide reductases (RNRs) are glycyl radical enzymes encoded by nrdD. The glycyl radical is installed by a glycyl radical enzyme activating enzyme (GRE-AE) encoded by nrdE. The GRE-AE reductively cleaves S-adenosyl-L-methionine to form methionine and a 5'-deoxyadenosyl-radical. The latter abstracts hydrogen from an active site glycine residue of NrdD. The glycyl radical then abstracts hydrogen from a cysteine to form a thiyl radical, which initiates the conversion of nucleotides to deoxynucleotides. Reducing equivalents for this reaction are supplied by formate, forming CO2 as a byproduct. As with pyruvate formate lyase, O2 reacts with the glycyl radical resulting in cleavage of the polypeptide backbone. (B) Class Ia RNR contains a diferrous iron site on the NrdB (R2) subunit, which reacts with O2 to form a diferric oxygen center and a stable tyrosyl radical. The radical is transmitted to a cysteine in the NrdA (R1) subunit to form a thiyl radical that facilitates the conversion of nucleotides to deoxynucleotides. The reducing equivalents for the reaction are supplied by a pair of thiols for two cysteine side chains. The resulting disulfide is likely reduced by a glutaredoxin (Grx), encoded by grx and pyridine-nucleotide dependent ferredoxin-like flavin reductase (FNR), transcribed in the reverse direction (fnr).
Notably, F. nucleatum also encodes for a Class I RNR (FN0102-FN0103, NdrAB), which is unexpected given the reliance of Class I RNR on O2 for the formation of the tyrosyl radical. Presumably, F. nucleatum utilizes NdrAB to maintain a balanced dNTP pool in the event of O2 inactivation of NrdD, exploiting temporary aerobiosis to generate the tyrosyl radical of NdrAB. The occurrence of Class I and III RNR in an anaerobe is not unprecedented, as Bacteroides fragilis, an obligate anaerobe capable of long-term survival in the presence of air, also encodes Class I and Class III RNR, with the former being induced during oxidative stress (168). However, it is perplexing as to why F. nucleatum did not employ a class II RNR to supplant the role of an inactive NrdD, given that class II RNR is O2 tolerant and that F. nucleatum—unlike Bacteroides fragilis—biosynthesizes adenosylcobalamin, the radical initiator for Class II RNR (169). Regardless, the presence of a Class I RNR constitutes an additional layer of defense against O2 and another system by which F. nucleatum can exploit O2 for survival.
CONCLUDING REMARKS
In summary, F. nucleatum can adapt to fluctuating oxygen environments through a diverse arsenal of oxidative stress mitigation strategies. These include enzymatic detoxification via peroxiredoxins, methionine sulfoxide reductases, rubrerythrin, and flavodiiron proteins, as well as metabolic shifts that minimize ROS-induced damage. Moreover, F. nucleatum exploits oxygen for energy conservation, as evidenced by its butyryl-CoA oxygen oxidoreductase system. Additionally, the ModRS two-component regulatory system plays a crucial role in orchestrating metabolic adaptations to counterbalance the inactivation of the oxygen poisoning of pyruvate formate lyase. These adaptive mechanisms likely support F. nucleatum’s survival in the oral biofilm and its dissemination to extraoral sites, contributing to its association with systemic diseases, including cancer. A deeper understanding of these oxygen adaptation strategies may inform novel therapeutic interventions aimed at mitigating the pathogenic potential of F. nucleatum in both oral and systemic infections.
Contributor Information
Kirsten R. Wolthers, Email: kirsten.wolthers@ubc.ca.
Michael Y. Galperin, National Institutes of Health, Bethesda, Maryland, USA
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/jb.00090-25.
Gene numbers for F. nucleatum subsp. nucleatum ATCC 25586 and ATCC 23726.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Sakanaka A, Kuboniwa M, Shimma S, Alghamdi SA, Mayumi S, Lamont RJ, Fukusaki E, Amano A. 2022. Fusobacterium nucleatum metabolically integrates commensals and pathogens in oral biofilms. mSystems 7:e0017022. doi: 10.1128/msystems.00170-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. 2010. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8:471–480. doi: 10.1038/nrmicro2381 [DOI] [PubMed] [Google Scholar]
- 3. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. 2003. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 11:94–100. doi: 10.1016/s0966-842x(02)00034-3 [DOI] [PubMed] [Google Scholar]
- 4. Mark Welch JL, Rossetti BJ, Rieken CW, Dewhirst FE, Borisy GG. 2016. Biogeography of a human oral microbiome at the micron scale. Proc Natl Acad Sci USA 113:E791–E800. doi: 10.1073/pnas.1522149113 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Baker JL, Mark Welch JL, Kauffman KM, McLean JS, He X. 2024. The oral microbiome: diversity, biogeography and human health. Nat Rev Microbiol 22:89–104. doi: 10.1038/s41579-023-00963-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Mark Welch JL, Ramírez-Puebla ST, Borisy GG. 2020. Oral microbiome geography: micron-scale habitat and niche. Cell Host Microbe 28:160–168. doi: 10.1016/j.chom.2020.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Storz G, Imlay JA. 1999. Oxidative stress. Curr Opin Microbiol 2:188–194. doi: 10.1016/s1369-5274(99)80033-2 [DOI] [PubMed] [Google Scholar]
- 8. Abranches J, Zeng L, Kajfasz JK, Palmer SR, Chakraborty B, Wen ZT, Richards VP, Brady LJ, Lemos JA. 2018. Biology of oral streptococci. Microbiol Spectr 6. doi: 10.1128/microbiolspec.gpp3-0042-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Brennan CA, Garrett WS. 2019. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol 17:156–166. doi: 10.1038/s41579-018-0129-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Coppenhagen-Glazer S, Sol A, Abed J, Naor R, Zhang X, Han YW, Bachrach G. 2015. Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth. Infect Immun 83:1104–1113. doi: 10.1128/IAI.02838-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Wang X, Buhimschi CS, Temoin S, Bhandari V, Han YW, Buhimschi IA. 2013. Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis. PLoS One 8:e56131. doi: 10.1371/journal.pone.0056131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS. 2009. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 47:38–47. doi: 10.1128/JCM.01206-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Han YW, Redline RW, Li M, Yin L, Hill GB, McCormick TS. 2004. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 72:2272–2279. doi: 10.1128/IAI.72.4.2272-2279.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22:299–306. doi: 10.1101/gr.126516.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. 2012. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 22:292–298. doi: 10.1101/gr.126573.111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Chang C, Geng F, Shi X, Li Y, Zhang X, Zhao X, Pan Y. 2019. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma. Appl Microbiol Biotechnol 103:1393–1404. doi: 10.1007/s00253-018-9475-6 [DOI] [PubMed] [Google Scholar]
- 17. Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, Yao JZ, Baddour LM, Chia N, Degnim AC. 2016. The microbiome of aseptically collected human breast tissue in benign and malignant disease. Sci Rep 6:30751. doi: 10.1038/srep30751 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Mitsuhashi K, Nosho K, Sukawa Y, Matsunaga Y, Ito M, Kurihara H, Kanno S, Igarashi H, Naito T, Adachi Y, Tachibana M, Tanuma T, Maguchi H, Shinohara T, Hasegawa T, Imamura M, Kimura Y, Hirata K, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. 2015. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget 6:7209–7220. doi: 10.18632/oncotarget.3109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Udayasuryan B, Ahmad RN, Nguyen TTD, Umaña A, Monét Roberts L, Sobol P, Jones SD, Munson JM, Slade DJ, Verbridge SS. 2022. Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling. Sci Signal 15:eabn4948. doi: 10.1126/scisignal.abn4948 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Zhang JW, Zhang D, Yin HS, Zhang H, Hong KQ, Yuan JP, Yu BP. 2023. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway. Gut Microbes 15:2197836. doi: 10.1080/19490976.2023.2197836 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Flanagan L, Schmid J, Ebert M, Soucek P, Kunicka T, Liska V, Bruha J, Neary P, Dezeeuw N, Tommasino M, Jenab M, Prehn JHM, Hughes DJ. 2014. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 33:1381–1390. doi: 10.1007/s10096-014-2081-3 [DOI] [PubMed] [Google Scholar]
- 22. Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, et al. 2017. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358:1443–1448. doi: 10.1126/science.aal5240 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, Nissan A, Sandbank J, Yehuda-Shnaidman E, Ponath F, Vogel J, Mandelboim O, Granot Z, Straussman R, Bachrach G. 2020. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun 11:3259. doi: 10.1038/s41467-020-16967-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, Chen Y, Chen H, Hong J, Zou W, Fang JY. 2017. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell 170:548–563. doi: 10.1016/j.cell.2017.07.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Kostic AD, Chun EY, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-Immune microenvironment. Cell Host Microbe 14:207–215. doi: 10.1016/j.chom.2013.07.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Zhang L, Leng X-X, Qi J, Wang N, Han J-X, Tao Z-H, Zhuang Z-Y, Ren Y, Xie Y-L, Jiang S-S, Li J-L, Chen H, Zhou C-B, Cui Y, Chen X, Wang Z, Zhang Z-Z, Hong J, Chen H-Y, Jiang W, Chen Y-X, Zhao X, Yu J, Fang J-Y. 2024. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis. Nat Microbiol 9:2292–2307. doi: 10.1038/s41564-024-01784-w [DOI] [PubMed] [Google Scholar]
- 27. Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. 2013. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14:195–206. doi: 10.1016/j.chom.2013.07.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Guo P, Tian Z, Kong X, Yang L, Shan X, Dong B, Ding X, Jing X, Jiang C, Jiang N, Yu Y. 2020. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2. J Exp Clin Cancer Res 39:202. doi: 10.1186/s13046-020-01677-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Abed J, Emgård JEM, Zamir G, Faroja M, Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, Mellul A, Chaushu S, Manson AL, Earl AM, Ou N, Brennan CA, Garrett WS, Bachrach G. 2016. Fap2 Mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20:215–225. doi: 10.1016/j.chom.2016.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O. 2015. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42:344–355. doi: 10.1016/j.immuni.2015.01.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Han YW, Shi W, Huang GT, Kinder Haake S, Park NH, Kuramitsu H, Genco RJ. 2000. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 68:3140–3146. doi: 10.1128/IAI.68.6.3140-3146.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Weiss EI, Shaniztki B, Dotan M, Ganeshkumar N, Kolenbrander PE, Metzger Z. 2000. Attachment of Fusobacterium nucleatum PK1594 to mammalian cells and its coaggregation with periodontopathogenic bacteria are mediated by the same galactose-binding adhesin. Oral Microbiol Immunol 15:371–377. doi: 10.1034/j.1399-302x.2000.150606.x [DOI] [PubMed] [Google Scholar]
- 33. Ikegami A, Chung P, Han YW. 2009. Complementation of the fadA mutation in Fusobacterium nucleatum demonstrates that the surface-exposed adhesin promotes cellular invasion and placental colonization. Infect Immun 77:3075–3079. doi: 10.1128/IAI.00209-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Parhi L, Abed J, Shhadeh A, Alon-Maimon T, Udi S, Ben-Arye SL, Tam J, Parnas O, Padler-Karavani V, Goldman-Wohl D, Yagel S, Mandelboim O, Bachrach G. 2022. Placental colonization by Fusobacterium nucleatum is mediated by binding of the Fap2 lectin to placentally displayed Gal-GalNAc. Cell Rep 38:110537. doi: 10.1016/j.celrep.2022.110537 [DOI] [PubMed] [Google Scholar]
- 35. Abed J, Maalouf N, Manson AL, Earl AM, Parhi L, Emgård JEM, Klutstein M, Tayeb S, Almogy G, Atlan KA, Chaushu S, Israeli E, Mandelboim O, Garrett WS, Bachrach G. 2020. Colon Cancer-associated Fusobacterium nucleatum may originate from the oral cavity and reach colon tumors via the circulatory system. Front Cell Infect Microbiol 10:400. doi: 10.3389/fcimb.2020.00400 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Gonzales-Marin C, Spratt DA, Allaker RP. 2013. Maternal oral origin of Fusobacterium nucleatum in adverse pregnancy outcomes as determined using the 16S-23S rRNA gene intergenic transcribed spacer region. J Med Microbiol 62:133–144. doi: 10.1099/jmm.0.049452-0 [DOI] [PubMed] [Google Scholar]
- 37. Gauthier S, Tétu A, Himaya E, Morand M, Chandad F, Rallu F, Bujold E. 2011. The origin of Fusobacterium nucleatum involved in intra-amniotic infection and preterm birth. J Matern Fetal Neonatal Med 24:1329–1332. doi: 10.3109/14767058.2010.550977 [DOI] [PubMed] [Google Scholar]
- 38. Farias FF, Lima FL, Carvalho MAR, Nicoli JR, Farias LM. 2001. Influence of isolation site, laboratory handling and growth stage on oxygen tolerance of Fusobacterium strains. Anaerobe 7:271–276. doi: 10.1006/anae.2001.0392 [DOI] [Google Scholar]
- 39. Gursoy UK, Pöllänen M, Könönen E, Uitto V-J. 2010. Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model. J Periodontol 81:1084–1091. doi: 10.1902/jop.2010.090664 [DOI] [PubMed] [Google Scholar]
- 40. Bradshaw DJ, Marsh PD, Watson GK, Allison C. 1998. Role of Fusobacterium nucleatum and coaggregation in anaerobe survival in planktonic and biofilm oral microbial communities during aeration. Infect Immun 66:4729–4732. doi: 10.1128/IAI.66.10.4729-4732.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Diaz PI, Zilm PS, Rogers AH. 2002. Fusobacterium nucleatum supports the growth of Porphyromonas gingivalis in oxygenated and carbon-dioxide-depleted environments. Microbiology (Reading) 148:467–472. doi: 10.1099/00221287-148-2-467 [DOI] [PubMed] [Google Scholar]
- 42. Diaz PI, Zilm PS, Rogers AH. 2000. The response to oxidative stress of Fusobacterium nucleatum grown in continuous culture. FEMS Microbiol Lett 187:31–34. doi: 10.1111/j.1574-6968.2000.tb09132.x [DOI] [PubMed] [Google Scholar]
- 43. Chen L, Ge X, Dou Y, Wang X, Patel JR, Xu P. 2011. Identification of hydrogen peroxide production-related genes in Streptococcus sanguinis and their functional relationship with pyruvate oxidase. Microbiology (Reading, Engl) 157:13–20. doi: 10.1099/mic.0.039669-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Taniai H, Iida K, Seki M, Saito M, Shiota S, Nakayama H, Yoshida S. 2008. Concerted action of lactate oxidase and pyruvate oxidase in aerobic growth of Streptococcus pneumoniae: role of lactate as an energy source. J Bacteriol 190:3572–3579. doi: 10.1128/JB.01882-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Imlay JA. 2013. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat Rev Microbiol 11:443–454. doi: 10.1038/nrmicro3032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Halliwell B, Adhikary A, Dingfelder M, Dizdaroglu M. 2021. Hydroxyl radical is a significant player in oxidative DNA damage in vivo. Chem Soc Rev 50:8355–8360. doi: 10.1039/d1cs00044f [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Kreth J, Zhang Y, Herzberg MC. 2008. Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J Bacteriol 190:4632–4640. doi: 10.1128/JB.00276-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Williams I, Tuckerman JS, Peters DI, Bangs M, Williams E, Shin IJ, Kaspar JR. 2025. A strain of Streptococcus mitis inhibits biofilm formation of caries pathogens via abundant hydrogen peroxide production. Appl Environ Microbiol 91:e0219224. doi: 10.1128/aem.02192-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Huang X, Palmer SR, Ahn S-J, Richards VP, Williams ML, Nascimento MM, Burne RA. 2016. A highly arginolytic Streptococcus species that potently antagonizes Streptococcus mutans. Appl Environ Microbiol 82:2187–2201. doi: 10.1128/AEM.03887-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Redanz S, Cheng X, Giacaman RA, Pfeifer CS, Merritt J, Kreth J. 2018. Live and let die: hydrogen peroxide production by the commensal flora and its role in maintaining a symbiotic microbiome. Mol Oral Microbiol 33:337–352. doi: 10.1111/omi.12231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Thurnheer T, Belibasakis GN. 2018. Streptococcus oralis maintains homeostasis in oral biofilms by antagonizing the cariogenic pathogen Streptococcus mutans. Mol Oral Microbiol 33:234–239. doi: 10.1111/omi.12216 [DOI] [PubMed] [Google Scholar]
- 52. Kim D, Ito T, Hara A, Li Y, Kreth J, Koo H. 2022. Antagonistic interactions by a high H2O2-producing commensal streptococcus modulate caries development by Streptococcus mutans. Mol Oral Microbiol 37:244–255. doi: 10.1111/omi.12394 [DOI] [PubMed] [Google Scholar]
- 53. Yu S, Ma Q, Li Y, Zou J. 2023. Molecular and regulatory mechanisms of oxidative stress adaptation in Streptococcus mutans. Mol Oral Microbiol 38:1–8. doi: 10.1111/omi.12388 [DOI] [PubMed] [Google Scholar]
- 54. Pulliainen AT, Hytönen J, Haataja S, Finne J. 2008. Deficiency of the Rgg regulator promotes H2O2 resistance, AhpCF-mediated H2O2 decomposition, and virulence in Streptococcus pyogenes. J Bacteriol 190:3225–3235. doi: 10.1128/JB.01843-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Makhlynets O, Boal AK, Rhodes DV, Kitten T, Rosenzweig AC, Stubbe J. 2014. Streptococcus sanguinis class Ib ribonucleotide reductase: high activity with both iron and manganese cofactors and structural insights. J Biol Chem 289:6259–6272. doi: 10.1074/jbc.M113.533554 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Messner KR, Imlay JA. 1999. The identification of primary sites of superoxide and hydrogen peroxide formation in the aerobic respiratory chain and sulfite reductase complex of Escherichia coli. J Biol Chem 274:10119–10128. doi: 10.1074/jbc.274.15.10119 [DOI] [PubMed] [Google Scholar]
- 57. Massey V, Strickland S, Mayhew SG, Howell LG, Engel PC, Matthews RG, Schuman M, Sullivan PA. 1969. The production of superoxide anion radicals in the reaction of reduced flavins and flavoproteins with molecular oxygen. Biochem Biophys Res Commun 36:891–897. doi: 10.1016/0006-291x(69)90287-3 [DOI] [PubMed] [Google Scholar]
- 58. Das A, Coulter ED, Kurtz DM, Ljungdahl LG. 2001. Five-gene cluster in Clostridium thermoaceticum consisting of two divergent operons encoding rubredoxin oxidoreductase- rubredoxin and rubrerythrin-type A flavoprotein- high-molecular-weight rubredoxin. J Bacteriol 183:1560–1567. doi: 10.1128/JB.183.5.1560-1567.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. DuPlessis ER, Pellett J, Stankovich MT, Thorpe C. 1998. Oxidase activity of the acyl-CoA dehydrogenases. Biochemistry 37:10469–10477. doi: 10.1021/bi980767s [DOI] [PubMed] [Google Scholar]
- 60. Winterbourn CC, Kettle AJ, Hampton MB. 2016. Reactive oxygen species and neutrophil function. Annu Rev Biochem 85:765–792. doi: 10.1146/annurev-biochem-060815-014442 [DOI] [PubMed] [Google Scholar]
- 61. Aratani Y. 2018. Myeloperoxidase: its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys 640:47–52. doi: 10.1016/j.abb.2018.01.004 [DOI] [PubMed] [Google Scholar]
- 62. Hawkins CL, Pattison DI, Davies MJ. 2003. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 25:259–274. doi: 10.1007/s00726-003-0016-x [DOI] [PubMed] [Google Scholar]
- 63. Hawkins CL, Davies MJ. 1998. Hypochlorite-induced damage to proteins: formation of nitrogen-centred radicals from lysine residues and their role in protein fragmentation. Biochem J 332:617–625. doi: 10.1042/bj3320617 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Winterbourn CC. 1985. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim Biophys Acta 840:204–210. doi: 10.1016/0304-4165(85)90120-5 [DOI] [PubMed] [Google Scholar]
- 65. Nie S, Tian B, Wang X, Pincus DH, Welker M, Gilhuley K, Lu X, Han YW, Tang YW. 2015. Fusobacterium nucleatum subspecies identification by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 53:1399–1402. doi: 10.1128/JCM.00239-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Kook JK, Park SN, Lim YK, Cho E, Jo E, Roh H, Shin Y, Paek J, Kim HS, Kim H, Shin JH, Chang YH. 2017. Genome-based Reclassification of Fusobacterium nucleatum subspecies at the species level. Curr Microbiol 74:1137–1147. doi: 10.1007/s00284-017-1296-9 [DOI] [PubMed] [Google Scholar]
- 67. Perkins A, Nelson KJ, Parsonage D, Poole LB, Karplus PA. 2015. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci 40:435–445. doi: 10.1016/j.tibs.2015.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Ezraty B, Aussel L, Barras F. 2005. Methionine sulfoxide reductases in prokaryotes. Biochim Biophys Acta 1703:221–229. doi: 10.1016/j.bbapap.2004.08.017 [DOI] [PubMed] [Google Scholar]
- 69. Kapatral V, Anderson I, Ivanova N, Reznik G, Los T, Lykidis A, Bhattacharyya A, Bartman A, Gardner W, Grechkin G, Zhu L, Vasieva O, Chu L, Kogan Y, Chaga O, Goltsman E, Bernal A, Larsen N, D’Souza M, Walunas T, Pusch G, Haselkorn R, Fonstein M, Kyrpides N, Overbeek R. 2002. Genome sequence and analysis of the oral bacterium Fusobacterium nucleatum strain ATCC 25586. J Bacteriol 184:2005–2018. doi: 10.1128/JB.184.7.2005-2018.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Storz G, Jacobson FS, Tartaglia LA, Morgan RW, Silveira LA, Ames BN. 1989. An alkyl hydroperoxide reductase induced by oxidative stress in Salmonella typhimurium and Escherichia coli: genetic characterization and cloning of ahp. J Bacteriol 171:2049–2055. doi: 10.1128/jb.171.4.2049-2055.1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Jacobson FS, Morgan RW, Christman MF, Ames BN. 1989. An alkyl hydroperoxide reductase from Salmonella typhimurium involved in the defense of DNA against oxidative damage: purification and properties. J Biol Chem 264:1488–1496. doi: 10.1016/S0021-9258(18)94214-6 [DOI] [PubMed] [Google Scholar]
- 72. Peskin AV, Low FM, Paton LN, Maghzal GJ, Hampton MB, Winterbourn CC. 2007. The high reactivity of peroxiredoxin 2 with H2O2 is not reflected in its reaction with other oxidants and thiol reagents. J Biol Chem 282:11885–11892. doi: 10.1074/jbc.M700339200 [DOI] [PubMed] [Google Scholar]
- 73. Ellis HR, Poole LB. 1997. Roles for the two cysteine residues of AhpC in catalysis of peroxide reduction by alkyl hydroperoxide reductase from Salmonella typhimurium. Biochemistry 36:13349–13356. doi: 10.1021/bi9713658 [DOI] [PubMed] [Google Scholar]
- 74. Ponath F, Tawk C, Zhu Y, Barquist L, Faber F, Vogel J. 2021. RNA landscape of the emerging cancer-associated microbe Fusobacterium nucleatum. Nat Microbiol 6:1007–1020. doi: 10.1038/s41564-021-00927-7 [DOI] [PubMed] [Google Scholar]
- 75. Wood ZA, Poole LB, Karplus PA. 2001. Structure of intact AhpF reveals a mirrored thioredoxin-like active site and implies large domain rotations during catalysis. Biochemistry 40:3900–3911. doi: 10.1021/bi002765p [DOI] [PubMed] [Google Scholar]
- 76. Parsonage D, Youngblood DS, Sarma GN, Wood ZA, Karplus PA, Poole LB. 2005. Analysis of the link between enzymatic activity and oligomeric state in AhpC, a bacterial peroxiredoxin. Biochemistry 44:10583–10592. doi: 10.1021/bi050448i [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Poole LB, Ellis HR. 1996. Flavin-dependent alkyl hydroperoxide reductase from Salmonella typhimurium. 1. Purification and enzymatic activities of overexpressed AhpF and AhpC proteins. Biochemistry 35:56–64. doi: 10.1021/bi951887s [DOI] [PubMed] [Google Scholar]
- 78. Poole LB, Godzik A, Nayeem A, Schmitt JD. 2000. AhpF can be dissected into two functional units: tandem repeats of two thioredoxin-like folds in the Na-terminus mediate electron transfer from the thioredoxin reductase-like C-terminus to AhpC. Biochemistry 39:6602–6615. doi: 10.1021/bi000405w [DOI] [PubMed] [Google Scholar]
- 79. Bieger B, Essen LO. 2001. Crystal structure of the catalytic core component of the alkylhydroperoxide reductase AhpF from Escherichia coli. J Mol Biol 307:1–8. doi: 10.1006/jmbi.2000.4441 [DOI] [PubMed] [Google Scholar]
- 80. Li Calzi M, Poole LB. 1997. Requirement for the two AhpF cystine disulfide centers in catalysis of peroxide reduction by alkyl hydroperoxide reductase. Biochemistry 36:13357–13364. doi: 10.1021/bi9713660 [DOI] [PubMed] [Google Scholar]
- 81. Seaver LC, Imlay JA. 2001. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. J Bacteriol 183:7173–7181. doi: 10.1128/JB.183.24.7173-7181.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Ezraty B, Gennaris A, Barras F, Collet JF. 2017. Oxidative stress, protein damage and repair in bacteria. Nat Rev Microbiol 15:385–396. doi: 10.1038/nrmicro.2017.26 [DOI] [PubMed] [Google Scholar]
- 83. Pattison DI, Davies MJ. 2001. Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol 14:1453–1464. doi: 10.1021/tx0155451 [DOI] [PubMed] [Google Scholar]
- 84. Buxton GV, Greenstock CL, Helman WP, Ross AB. 1988. Critical Review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (⋅OH/⋅O− in Aqueous Solution. J Phys Chem Ref Data 17:513–886. doi: 10.1063/1.555805 [DOI] [Google Scholar]
- 85. Davies MJ. 2005. The oxidative environment and protein damage. Biochim Biophys Acta 1703:93–109. doi: 10.1016/j.bbapap.2004.08.007 [DOI] [PubMed] [Google Scholar]
- 86. Delaye L, Becerra A, Orgel L, Lazcano A. 2007. Molecular evolution of peptide methionine sulfoxide reductases (MsrA and MsrB): on the early development of a mechanism that protects against oxidative damage. J Mol Evol 64:15–32. doi: 10.1007/s00239-005-0281-2 [DOI] [PubMed] [Google Scholar]
- 87. Boschi-Muller S, Olry A, Antoine M, Branlant G. 2005. The enzymology and biochemistry of methionine sulfoxide reductases. Biochim Biophys Acta 1703:231–238. doi: 10.1016/j.bbapap.2004.09.016 [DOI] [PubMed] [Google Scholar]
- 88. Sharov VS, Ferrington DA, Squier TC, Schöneich C. 1999. Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase. FEBS Lett 455:247–250. doi: 10.1016/S0014-5793(99)00888-1 [DOI] [PubMed] [Google Scholar]
- 89. Kauffmann B, Favier F, Olry A, Boschi-Muller S, Carpentier P, Branlant G, Aubry A. 2002. Crystallization and preliminary X-ray diffraction studies of the peptide methionine sulfoxide reductase B domain of Neisseria meningitidis PILB. Acta Crystallogr D Biol Crystallogr 58:1467–1469. doi: 10.1107/S0907444902010570 [DOI] [PubMed] [Google Scholar]
- 90. Tossounian M-A, Pedre B, Wahni K, Erdogan H, Vertommen D, Van Molle I, Messens J. 2015. Corynebacterium diphtheriae methionine sulfoxide reductase a exploits a unique mycothiol redox relay mechanism. J Biol Chem 290:11365–11375. doi: 10.1074/jbc.M114.632596 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91. Sastre S, Manta B, Semelak JA, Estrin D, Trujillo M, Radi R, Zeida A. 2024. Catalytic mechanism of Mycobacterium tuberculosis methionine sulfoxide reductase A. Biochemistry 63:533–544. doi: 10.1021/acs.biochem.3c00504 [DOI] [PubMed] [Google Scholar]
- 92. Lowther WT, Weissbach H, Etienne F, Brot N, Matthews BW. 2002. The mirrored methionine sulfoxide reductases of Neisseria gonorrhoeae pilB. Nat Struct Biol 9:348–352. doi: 10.1038/nsb783 [DOI] [PubMed] [Google Scholar]
- 93. Taylor AB, Benglis DM, Dhandayuthapani S, Hart PJ. 2003. Structure of Mycobacterium tuberculosis methionine sulfoxide reductase A in complex with protein-bound methionine. J Bacteriol 185:4119–4126. doi: 10.1128/JB.185.14.4119-4126.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Antoine M, Boschi-Muller S, Branlant G. 2003. Kinetic characterization of the chemical steps involved in the catalytic mechanism of methionine sulfoxide reductase A from Neisseria meningitidis. J Biol Chem 278:45352–45357. doi: 10.1074/jbc.M307471200 [DOI] [PubMed] [Google Scholar]
- 95. Lowther WT, Brot N, Weissbach H, Honek JF, Matthews BW. 2000. Thiol-disulfide exchange is involved in the catalytic mechanism of peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 97:6463–6468. doi: 10.1073/pnas.97.12.6463 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96. Wu J, Neiers F, Boschi-Muller S, Branlant G. 2005. The N-terminal domain of PILB from Neisseria meningitidis is a disulfide reductase that can recycle methionine sulfoxide reductases. J Biol Chem 280:12344–12350. doi: 10.1074/jbc.M500385200 [DOI] [PubMed] [Google Scholar]
- 97. Brot N, Collet J-F, Johnson LC, Jönsson TJ, Weissbach H, Lowther WT. 2006. The thioredoxin domain of Neisseria gonorrhoeae PilB can use electrons from DsbD to reduce downstream methionine sulfoxide reductases. J Biol Chem 281:32668–32675. doi: 10.1074/jbc.M604971200 [DOI] [PubMed] [Google Scholar]
- 98. Scheible M, Nguyen CT, Luong TT, Lee JH, Chen YW, Chang C, Wittchen M, Camacho MI, Tiner BL, Wu C, Tauch A, Das A, Ton-That H. 2022. The fused methionine sulfoxide reductase MsrAB promotes oxidative stress defense and bacterial virulence in Fusobacterium nucleatum. mBio 13:e0302221. doi: 10.1128/mbio.03022-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99. Jalal NA, Davey L, Halperin SA, Lee SF. 2019. Identification of redox partners of the thiol-disulfide oxidoreductase SdbA in Streptococcus gordonii. J Bacteriol 201:e00030-19. doi: 10.1128/JB.00030-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100. Williamson JA, Cho S-H, Ye J, Collet J-F, Beckwith JR, Chou JJ. 2015. Structure and multistate function of the transmembrane electron transporter CcdA. Nat Struct Mol Biol 22:809–814. doi: 10.1038/nsmb.3099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101. Teufel F, Almagro Armenteros JJ, Johansen AR, Gíslason MH, Pihl SI, Tsirigos KD, Winther O, Brunak S, von Heijne G, Nielsen H. 2022. SignalP 6.0 predicts all five types of signal peptides using protein language models. Nat Biotechnol 40:1023–1025. doi: 10.1038/s41587-021-01156-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102. Baltes N, Hennig-Pauka I, Jacobsen I, Gruber AD, Gerlach GF. 2003. Identification of dimethyl sulfoxide reductase in Actinobacillus pleuropneumoniae and its role in infection. Infect Immun 71:6784–6792. doi: 10.1128/IAI.71.12.6784-6792.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103. Denkel LA, Rhen M, Bange FC. 2013. Biotin sulfoxide reductase contributes to oxidative stress tolerance and virulence in Salmonella enterica serovar Typhimurium. Microbiology (Reading, Engl) 159:1447–1458. doi: 10.1099/mic.0.067256-0 [DOI] [PubMed] [Google Scholar]
- 104. Dhouib R, Othman DSMP, Lin V, Lai XJ, Wijesinghe HGS, Essilfie A-T, Davis A, Nasreen M, Bernhardt PV, Hansbro PM, McEwan AG, Kappler U. 2016. A novel, molybdenum-containing methionine sulfoxide reductase supports survival of Haemophilus influenzae in an in vivo model of infection. Front Microbiol 7:1743. doi: 10.3389/fmicb.2016.01743 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105. Dhouib R, Nasreen M, Othman D, Ellis D, Lee S, Essilfie A-T, Hansbro PM, McEwan AG, Kappler U. 2021. The DmsABC sulfoxide reductase supports virulence in non-typeable Haemophilus influenzae. Front Microbiol 12:686833. doi: 10.3389/fmicb.2021.686833 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106. Nasreen M, Ellis D, Hosmer J, Essilfie AT, Fantino E, Sly P, McEwan AG, Kappler U. 2024. The DmsABC S-oxide reductase is an essential component of a novel, hypochlorite-inducible system of extracellular stress defense in Haemophilus influenzae. Front Microbiol 15:1359513. doi: 10.3389/fmicb.2024.1359513 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107. LeGall J, Prickril BC, Moura I, Xavier AV, Moura JJ, Huynh BH. 1988. Isolation and characterization of rubrerythrin, a non-heme iron protein from Desulfovibrio vulgaris that contains rubredoxin centers and a hemerythrin-like binuclear iron cluster. Biochemistry 27:1636–1642. doi: 10.1021/bi00405a037 [DOI] [PubMed] [Google Scholar]
- 108. Sztukowska M, Bugno M, Potempa J, Travis J, Kurtz DM Jr. 2002. Role of rubrerythrin in the oxidative stress response of Porphyromonas gingivalis. Mol Microbiol 44:479–488. doi: 10.1046/j.1365-2958.2002.02892.x [DOI] [PubMed] [Google Scholar]
- 109. May A, Hillmann F, Riebe O, Fischer RJ, Bahl H. 2004. A rubrerythrin-like oxidative stress protein of Clostridium acetobutylicum is encoded by a duplicated gene and identical to the heat shock protein Hsp21. FEMS Microbiol Lett 238:249–254. doi: 10.1111/j.1574-6968.2004.tb09763.x [DOI] [PubMed] [Google Scholar]
- 110. Lumppio HL, Shenvi NV, Summers AO, Voordouw G, Kurtz DM Jr. 2001. Rubrerythrin and rubredoxin oxidoreductase in Desulfovibrio vulgaris: a novel oxidative stress protection system. J Bacteriol 183:101–108. doi: 10.1128/JB.183.1.101-108.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111. Weinberg MV, Jenney FE Jr, Cui X, Adams MWW. 2004. Rubrerythrin from the hyperthermophilic archaeon Pyrococcus furiosus is a rubredoxin-dependent, iron-containing peroxidase. J Bacteriol 186:7888–7895. doi: 10.1128/JB.186.23.7888-7895.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112. Lotoux A, Caulat L, Martins Alves C, Alves Feliciano C, Morvan C, Folgosa F, Martin-Verstraete I. 2025. Defense arsenal of the strict anaerobe Clostridioides difficile against reactive oxygen species encountered during its infection cycle. mBio 16:e0375324. doi: 10.1128/mbio.03753-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113. Riebe O, Fischer RJ, Wampler DA, Kurtz DM, Bahl H. 2009. Pathway for H2O2 and O2 detoxification in Clostridium acetobutylicum. Microbiology (Reading) 155:16–24. doi: 10.1099/mic.0.022756-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114. deMaré F, Kurtz DM, Nordlund P. 1996. The structure of Desulfovibrio vulgaris rubrerythrin reveals a unique combination of rubredoxin-like FeS4 and ferritin-like diiron domains. Nat Struct Mol Biol 3:539–546. doi: 10.1038/nsb0696-539 [DOI] [PubMed] [Google Scholar]
- 115. Jin S, Kurtz, DM, Liu Z-J, Rose J, Wang B-C. 2002. X-ray crystal structures of reduced rubrerythrin and its azide adduct: a structure-based mechanism for a non-heme diiron peroxidase. J Am Chem Soc 124:9845–9855. doi: 10.1021/ja026587u [DOI] [PubMed] [Google Scholar]
- 116. Kurtz DM Jr. 2006. Avoiding high-valent iron intermediates: superoxide reductase and rubrerythrin. J Inorg Biochem 100:679–693. doi: 10.1016/j.jinorgbio.2005.12.017 [DOI] [PubMed] [Google Scholar]
- 117. Vicente JB, Teixeira M. 2005. Redox and spectroscopic properties of the Escherichia coli nitric oxide-detoxifying system involving flavorubredoxin and its NADH-oxidizing redox partner. J Biol Chem 280:34599–34608. doi: 10.1074/jbc.M506349200 [DOI] [PubMed] [Google Scholar]
- 118. Romão CV, Vicente JB, Borges PT, Frazão C, Teixeira M. 2016. The dual function of flavodiiron proteins: oxygen and/or nitric oxide reductases. J Biol Inorg Chem 21:39–52. doi: 10.1007/s00775-015-1329-4 [DOI] [PubMed] [Google Scholar]
- 119. Carrondo MA, Frazão C, Silva G, Gomes CM, Matias P, Coelho R, Sieker L, Macedo S, Liu MY, Oliveira S, Teixeira M, Xavier AV, Rodrigues-Pousada C, Le Gall J. 2000. Structure of a dioxygen reduction enzyme from Desulfovibrio gigas. Nat Struct Biol 7:1041–1045. doi: 10.1038/80961 [DOI] [PubMed] [Google Scholar]
- 120. Silaghi-Dumitrescu R, Coulter ED, Das A, Ljungdahl LG, Jameson GNL, Huynh BH, Kurtz DM. 2003. A flavodiiron protein and high molecular weight rubredoxin from Moorella thermoacetica with nitric oxide reductase activity. Biochemistry 42:2806–2815. doi: 10.1021/bi027253k [DOI] [PubMed] [Google Scholar]
- 121. Romão CV, Vicente JB, Borges PT, Victor BL, Lamosa P, Silva E, Pereira L, Bandeiras TM, Soares CM, Carrondo MA, Turner D, Teixeira M, Frazão C. 2016. Structure of Escherichia coli flavodiiron nitric oxide reductase. J Mol Biol 428:4686–4707. doi: 10.1016/j.jmb.2016.10.008 [DOI] [PubMed] [Google Scholar]
- 122. Silaghi-Dumitrescu R, Kurtz DM, Ljungdahl LG, Lanzilotta WN. 2005. X-ray crystal structures of Moorella thermoacetica FprA. Novel diiron site structure and mechanistic insights into a scavenging nitric oxide reductase. Biochemistry 44:6492–6501. doi: 10.1021/bi0473049 [DOI] [PubMed] [Google Scholar]
- 123. Folgosa F, Martins MC, Teixeira M. 2018. Diversity and complexity of flavodiiron NO/O2 reductases. FEMS Microbiol Lett 365. doi: 10.1093/femsle/fnx267 [DOI] [PubMed] [Google Scholar]
- 124. Martins MC, Romão CV, Folgosa F, Borges PT, Frazão C, Teixeira M. 2019. How superoxide reductases and flavodiiron proteins combat oxidative stress in anaerobes. Free Radic Biol Med 140:36–60. doi: 10.1016/j.freeradbiomed.2019.01.051 [DOI] [PubMed] [Google Scholar]
- 125. Folgosa F, Martins MC, Teixeira M. 2018. The multidomain flavodiiron protein from Clostridium difficile 630 is an NADH:oxygen oxidoreductase. Sci Rep 8:10164. doi: 10.1038/s41598-018-28453-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126. Rodrigues R, Vicente JB, Félix R, Oliveira S, Teixeira M, Rodrigues-Pousada C. 2006. Desulfovibrio gigas flavodiiron protein affords protection against nitrosative stress in vivo. J Bacteriol 188:2745–2751. doi: 10.1128/JB.188.8.2745-2751.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127. Martins MC, Alves CM, Teixeira M, Folgosa F. 2024. The flavodiiron protein from Syntrophomonas wolfei has five domains and acts both as an NADH:O2 or an NADH:H2O2 oxidoreductase. FEBS J 291:1275–1294. doi: 10.1111/febs.17040 [DOI] [PubMed] [Google Scholar]
- 128. Bystrom LT, Wolthers KR. 2024. New electron-transfer chain to a flavodiiron protein in Fusobacterium nucleatum couples butyryl-CoA oxidation to O2 reduction. Biochemistry 63:2352–2368. doi: 10.1021/acs.biochem.4c00279 [DOI] [PubMed] [Google Scholar]
- 129. Buckel W. 2021. Energy conservation in fermentations of anaerobic bacteria. Front Microbiol 12:703525. doi: 10.3389/fmicb.2021.703525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130. Zhao T, Chen J, Liu S, Yang J, Wu J, Miao L, Sun W. 2022. Transcriptome analysis of Fusobacterium nucleatum reveals differential gene expression patterns in the biofilm versus planktonic cells. Biochem Biophys Res Commun 593:151–157. doi: 10.1016/j.bbrc.2021.11.075 [DOI] [PubMed] [Google Scholar]
- 131. Anand S, Kaur H, Mande SS. 2016. Comparative in silico analysis of butyrate production pathways in gut commensals and pathogens. Front Microbiol 7:1945. doi: 10.3389/fmicb.2016.01945 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132. Buckel W. 2001. Unusual enzymes involved in five pathways of glutamate fermentation. Appl Microbiol Biotechnol 57:263–273. doi: 10.1007/s002530100773 [DOI] [PubMed] [Google Scholar]
- 133. Wu CG, Chen YW, Scheible M, Chang CY, Wittchen M, Lee JH, Luong TT, Tiner BL, Tauch A, Das A, Ton-That H. 2021. Genetic and molecular determinants of polymicrobial interactions in Fusobacterium nucleatum. Proc Natl Acad Sci USA 118:e2006482118. doi: 10.1073/pnas.2006482118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134. Dzink JL, Socransky SS. 1990. Amino acid utilization by Fusobacterium nucleatum grown in a chemically defined medium. Oral Microbiol Immunol 5:172–174. doi: 10.1111/j.1399-302x.1990.tb00418.x [DOI] [PubMed] [Google Scholar]
- 135. Mohamed-Raseek N, Duan HD, Hildebrandt P, Mroginski MA, Miller AF. 2019. Spectroscopic, thermodynamic and computational evidence of the locations of the FADs in the nitrogen fixation-associated electron transfer flavoprotein. Chem Sci 10:7762–7772. doi: 10.1039/c9sc00942f [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136. Li F, Hinderberger J, Seedorf H, Zhang J, Buckel W, Thauer RK. 2008. Coupled ferredoxin and crotonyl coenzyme A (CoA) reduction with NADH catalyzed by the butyryl-CoA dehydrogenase/Etf complex from Clostridium kluyveri. J Bacteriol 190:843–850. doi: 10.1128/JB.01417-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137. Herrmann G, Jayamani E, Mai G, Buckel W. 2008. Energy conservation via electron-transferring flavoprotein in anaerobic bacteria. J Bacteriol 190:784–791. doi: 10.1128/JB.01422-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138. Schmehl M, Jahn A, Meyer zu Vilsendorf A, Hennecke S, Masepohl B, Schuppler M, Marxer M, Oelze J, Klipp W. 1993. Identification of a new class of nitrogen fixation genes in Rhodobacter capsulatus: a putative membrane complex involved in electron transport to nitrogenase. Mol Gen Genet 241:602–615. doi: 10.1007/BF00279903 [DOI] [PubMed] [Google Scholar]
- 139. Britton TA, Wu C, Chen YW, Franklin D, Chen Y, Camacho MI, Luong TT, Das A, Ton-That H. 2024. The respiratory enzyme complex Rnf is vital for metabolic adaptation and virulence in Fusobacterium nucleatum. mBio 15:e0175123. doi: 10.1128/mbio.01751-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140. Buckel W, Thauer RK. 2013. Energy conservation via electron bifurcating ferredoxin reduction and proton/Na+ translocating ferredoxin oxidation. Biochim Biophys Acta 1827:94–113. doi: 10.1016/j.bbabio.2012.07.002 [DOI] [PubMed] [Google Scholar]
- 141. Guan X, Li W, Meng H. 2021. A double-edged sword: role of butyrate in the oral cavity and the gut. Mol Oral Microbiol 36:121–131. doi: 10.1111/omi.12322 [DOI] [PubMed] [Google Scholar]
- 142. Louis P, Flint HJ. 2009. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1–8. doi: 10.1111/j.1574-6968.2009.01514.x [DOI] [PubMed] [Google Scholar]
- 143. Bender RA. 2012. Regulation of the histidine utilization (hut) system in bacteria. Microbiol Mol Biol Rev 76:565–584. doi: 10.1128/MMBR.00014-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144. Brosnan ME, MacMillan L, Stevens JR, Brosnan JT. 2015. Division of labour: how does folate metabolism partition between one-carbon metabolism and amino acid oxidation? Biochem J 472:135–146. doi: 10.1042/BJ20150837 [DOI] [PubMed] [Google Scholar]
- 145. Wagner AF, Frey M, Neugebauer FA, Schäfer W, Knappe J. 1992. The free radical in pyruvate formate-lyase is located on glycine-734. Proc Natl Acad Sci USA 89:996–1000. doi: 10.1073/pnas.89.3.996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146. Shisler KA, Broderick JB. 2014. Glycyl radical activating enzymes: structure, mechanism, and substrate interactions. Arch Biochem Biophys 546:64–71. doi: 10.1016/j.abb.2014.01.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147. Knappe J, Neugebauer FA, Blaschkowski HP, Gänzler M. 1984. Post-translational activation introduces a free radical into pyruvate formate-lyase. Proc Natl Acad Sci USA 81:1332–1335. doi: 10.1073/pnas.81.5.1332 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148. Conradt H, Hohmann-Berger M, Hohmann HP, Blaschkowski HP, Knappe J. 1984. Pyruvate formate-lyase (inactive form) and pyruvate formate-lyase activating enzyme of Escherichia coli: isolation and structural properties. Arch Biochem Biophys 228:133–142. doi: 10.1016/0003-9861(84)90054-7 [DOI] [PubMed] [Google Scholar]
- 149. Broderick JB, Henshaw TF, Cheek J, Wojtuszewski K, Smith SR, Trojan MR, McGhan RM, Kopf A, Kibbey M, Broderick WE. 2000. Pyruvate formate-lyase-activating enzyme: strictly anaerobic isolation yields active enzyme containing a [3Fe–4S]+ cluster. Biochem Biophys Res Commun 269:451–456. doi: 10.1006/bbrc.2000.2313 [DOI] [PubMed] [Google Scholar]
- 150. Cheek J, Broderick JB. 2001. Adenosylmethionine-dependent iron-sulfur enzymes: versatile clusters in a radical new role. J Biol Inorg Chem 6:209–226. doi: 10.1007/s007750100210 [DOI] [PubMed] [Google Scholar]
- 151. Wang SC, Frey PA. 2007. S-adenosylmethionine as an oxidant: the radical SAM superfamily. Trends Biochem Sci 32:101–110. doi: 10.1016/j.tibs.2007.01.002 [DOI] [PubMed] [Google Scholar]
- 152. Licht S, Gerfen GJ, Stubbe J. 1996. Thiyl radicals in ribonucleotide reductases. Science 271:477–481. doi: 10.1126/science.271.5248.477 [DOI] [PubMed] [Google Scholar]
- 153. Wei Y, Mathies G, Yokoyama K, Chen J, Griffin RG, Stubbe J. 2014. A chemically competent thiosulfuranyl radical on the Escherichia coli class III ribonucleotide reductase. J Am Chem Soc 136:9001–9013. doi: 10.1021/ja5030194 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 154. Hioe J, Savasci G, Brand H, Zipse H. 2011. The stability of Cα peptide radicals: why glycyl radical enzymes? Chemistry 17:3781–3789. doi: 10.1002/chem.201002620 [DOI] [PubMed] [Google Scholar]
- 155. Knappe J, Wagner AF. 1995. Glycyl free radical in pyruvate formate-lyase: synthesis, structure characteristics, and involvement in catalysis. Methods Enzymol 258:343–362. doi: 10.1016/0076-6879(95)58055-7 [DOI] [PubMed] [Google Scholar]
- 156. Reddy SG, Wong KK, Parast CV, Peisach J, Magliozzo RS, Kozarich JW. 1998. Dioxygen inactivation of pyruvate formate-lyase: EPR evidence for the formation of protein-based sulfinyl and peroxyl radicals. Biochemistry 37:558–563. doi: 10.1021/bi972086n [DOI] [PubMed] [Google Scholar]
- 157. Zhang W, Wong KK, Magliozzo RS, Kozarich JW. 2001. Inactivation of pyruvate formate-lyase by dioxygen: defining the mechanistic interplay of glycine 734 and cysteine 419 by rapid freeze-quench EPR. Biochemistry 40:4123–4130. doi: 10.1021/bi002589k [DOI] [PubMed] [Google Scholar]
- 158. Kammel M, Sawers RG. 2022. The autonomous glycyl radical protein GrcA restores activity to inactive full-length pyruvate formate-lyase in vivo. J Bacteriol 204:e0007022. doi: 10.1128/jb.00070-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 159. Andorfer MC, Backman LRF, Li PL, Ulrich EC, Drennan CL. 2021. Rescuing activity of oxygen-damaged pyruvate formate-lyase by a spare part protein. J Biol Chem 297:101423. doi: 10.1016/j.jbc.2021.101423 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 160. Toraya T. 2003. Radical catalysis in coenzyme B12-dependent isomerization (eliminating) reactions. Chem Rev 103:2095–2127. doi: 10.1021/cr020428b [DOI] [PubMed] [Google Scholar]
- 161. Suwabe K, Yoshida Y, Nagano K, Yoshimura F. 2011. Identification of an l-methionine γ-lyase involved in the production of hydrogen sulfide from l-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586. Microbiology (Reading, Engl) 157:2992–3000. doi: 10.1099/mic.0.051813-0 [DOI] [PubMed] [Google Scholar]
- 162. Chen YW, Camacho MI, Chen Y, Bhat AH, Chang C, Peluso EA, Wu C, Das A, Ton-That H. 2022. Genetic determinants of hydrogen sulfide biosynthesis in Fusobacterium nucleatum are required for bacterial fitness, antibiotic sensitivity, and virulence. mBio 13:e0193622. doi: 10.1128/mbio.01936-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163. Nordlund P, Reichard P. 2006. Ribonucleotide reductases. Annu Rev Biochem 75:681–706. doi: 10.1146/annurev.biochem.75.103004.142443 [DOI] [PubMed] [Google Scholar]
- 164. Greene BL, Kang G, Cui C, Bennati M, Nocera DG, Drennan CL, Stubbe J. 2020. Ribonucleotide reductases: structure, chemistry, and metabolism suggest new therapeutic targets. Annu Rev Biochem 89:45–75. doi: 10.1146/annurev-biochem-013118-111843 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 165. Stubbe J, Nocera DG, Yee CS, Chang MCY. 2003. Radical initiation in the class I ribonucleotide reductase: long-range proton-coupled electron transfer? Chem Rev 103:2167–2201. doi: 10.1021/cr020421u [DOI] [PubMed] [Google Scholar]
- 166. Cotruvo JA, Stubbe J. 2011. Class I ribonucleotide reductases: metallocofactor assembly and repair in vitro and in vivo. Annu Rev Biochem 80:733–767. doi: 10.1146/annurev-biochem-061408-095817 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167. Fontecave M, Eliasson R, Reichard P. 1989. Oxygen-sensitive ribonucleoside triphosphate reductase is present in anaerobic Escherichia coli. Proc Natl Acad Sci USA 86:2147–2151. doi: 10.1073/pnas.86.7.2147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168. Smalley D, Rocha ER, Smith CJ. 2002. Aerobic-type ribonucleotide reductase in the anaerobe Bacteroides fragilis. J Bacteriol 184:895–903. doi: 10.1128/jb.184.4.895-903.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169. Moore SJ, Lawrence AD, Biedendieck R, Deery E, Frank S, Howard MJ, Rigby SEJ, Warren MJ. 2013. Elucidation of the anaerobic pathway for the corrin component of cobalamin (vitamin B12). Proc Natl Acad Sci USA 110:14906–14911. doi: 10.1073/pnas.1308098110 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Gene numbers for F. nucleatum subsp. nucleatum ATCC 25586 and ATCC 23726.




